Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | XAIR | Stock Options (Right to buy) | Disposed to Issuer | -300K | -100% | 0 | Nov 22, 2024 | Common Stock | 300K | $1.53 | Direct | F1, F2 | ||
transaction | XAIR | Stock Options (Right to buy) | Award | +300K | 300K | Nov 22, 2024 | Common Stock | 300K | $0.54 | Direct | F1, F2 | |||
transaction | XAIR | Stock Options (Right to buy) | Disposed to Issuer | -120K | -100% | 0 | Nov 22, 2024 | Common Stock | 120K | $6.28 | Direct | F1, F2 | ||
transaction | XAIR | Stock Options (Right to buy) | Award | +120K | 120K | Nov 22, 2024 | Common Stock | 120K | $0.54 | Direct | F1, F2 | |||
transaction | XAIR | Stock Options (Right to buy) | Disposed to Issuer | -20K | -100% | 0 | Nov 22, 2024 | Common Stock | 20K | $6.87 | Direct | F1, F2 | ||
transaction | XAIR | Stock Options (Right to buy) | Award | +20K | 20K | Nov 22, 2024 | Common Stock | 20K | $0.54 | Direct | F1, F2 | |||
transaction | XAIR | Stock Options (Right to buy) | Disposed to Issuer | -75K | -100% | 0 | Nov 22, 2024 | Common Stock | 75K | $10.68 | Direct | F1, F2 | ||
transaction | XAIR | Stock Options (Right to buy) | Award | +75K | 75K | Nov 22, 2024 | Common Stock | 75K | $0.54 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | On November 22, 2024, the Issuer's Board of Directors approved an option repricing, effective as of November 22, 2024 (the "Effective Date") reducing the exercise price to $0.54 per share, the closing price of the Issuer's common stock on the Effective Date. All of the other terms of the options remain unchanged. |
F2 | This stock option award was issued pursuant to the Company's Amended and Restated 2013 Equity Incentive Plan, as amended, (the "|2013 Plan") and becomes exercisable in accordance with the vesting schedule specified in the award agreement and as previously reported on applicable Form-4, subject to the Reporting Person's continued service with the Issuer as of the applicable vesting date. |